Find Academic Supervisors

Nabil MansourView profile

Associate Professor

• Gastroenterology
• Barrett's Esophagus
• Colorectal Cancer Screening
• +4 more

Nabil Mansour, M.D., is an Associate Professor and Director of the McNair General GI Clinic in the Department of Medicine-Gastroenterology at Baylor College of Medicine in Houston, TX. His clinical practice and research focus on advanced endoscopic interventions for gastrointestinal disorders. Education MD, American University of Beirut, Beirut, Lebanon Research Fellowship, American University of Beirut, Beirut, Lebanon Residency, University of Kansas School of Medicine-Wichita, Wichita, KS, United States Internal Medicine Clinical Fellowship, Baylor College of Medicine, Houston, TX, United States Research Focus Dr. Mansour specializes in Barrett's Esophagus therapies (radiofrequency ablation, cryotherapy), colorectal cancer screening using endoscopic mucosal resection (EMR), and optimization of colonoscopy techniques. His work bridges clinical practice with translational research in gastrointestinal oncology and therapeutic endoscopy. Publication Trends Recent publications (2011-2017) demonstrate a focus on evidence-based management of esophageal disorders, randomized controlled trials for GI therapies, and optimization of endoscopic cancer screening protocols. Key themes include Barrett's Esophagus surveillance, H. pylori eradication, and irritable bowel syndrome treatment. Awards AGA/AGA-GRG Fellow Abstract Prize (2016) Early Stage Investigator Certificate (2016) Research Award, University of Kansas (2014) ACG Presidential Poster Award (2013) Certifications & Memberships Board Certified: Internal Medicine & Gastroenterology (ABIM) American Gastroenterological Association American Society for Gastrointestinal Endoscopy American College of Gastroenterology

• Gastroenterology
• Advanced Endoscopy
• Pancreaticobiliary Disorders
• +4 more

Dr. Uzma Siddiqui is a Professor in the Department of Medicine-Gastroenterology at the University of Chicago. With extensive publication record spanning over a decade, she is a prominent researcher and clinician specializing in advanced gastrointestinal endoscopy, pancreaticobiliary disorders, and endoscopic ultrasound. Dr. Siddiqui's research interests span multiple areas of gastroenterology with a particular focus on: Advanced endoscopic procedures including ERCP and EUS Pancreatic cysts and pancreaticobiliary disorders Endoscopic management of gastrointestinal neoplasia Single-use endoscopic devices and infection control Gender disparities in gastroenterology Her work bridges clinical practice with innovative research to improve diagnostic and therapeutic endoscopic techniques. Analysis of Dr. Siddiqui's recent publications (2023-2025) reveals a strong emphasis on practical clinical applications of endoscopic techniques. Her research spans from technical innovations in endoscopic procedures to multicenter consensus guidelines. Notably, she has contributed to international expert consensus statements on post-procedural care after per-oral endoscopic myotomy and standards for referral of large colorectal polyps. Her work also addresses important systemic issues in gastroenterology, such as gender disparities in academic authorship. Dr. Siddiqui has been actively involved in numerous multicenter studies examining the efficacy and safety of various endoscopic techniques and devices. Her research often focuses on practical clinical questions that directly impact patient care in gastroenterology.

Mohamed O. OthmanView profile

Professor

• Endoscopic Submucosal Dissection
• Endoscopic Mucosal Resection
• Barrett's Esophagus Management
• +10 more

Mohamed O. Othman, M.D. is the Section Chief of Gastroenterology and Hepatology at Baylor College of Medicine and holds the Martha Ann and Harold M. Selzman, M.D. Endowed Chair. He practices at Baylor St. Luke's Medical Center in Houston, Texas, where he specializes in advanced endoscopic procedures and gastrointestinal disorders. Dr. Othman's educational background includes: BS from University of Mansoura School of Medicine (2003) - Mansoura, Egypt (M.B.Bch degree; Excellent with Grade of Honor) Residency at University of New Mexico School of Medicine (2007) - Internal Medicine Resident Fellowship at University of New Mexico School of Medicine (2010) - Gastroenterology and Hepatology Fellow Fellowship at Mayo Clinic Jacksonville (2011) - Advanced Endoscopy Fellow Dr. Othman is a leading expert in advanced endoscopic procedures with research interests spanning endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR), Barrett's Esophagus management, pancreatic disorders including chronic pancreatitis and pancreatic cysts, endoscopic ultrasound, ERCP, and innovative procedures like Per-Oral Endoscopic Myotomy (POEM). His work bridges clinical practice with cutting-edge research to improve outcomes for patients with complex gastrointestinal conditions. He has published extensively on endoscopic techniques and their applications in gastrointestinal diseases. Dr. Othman has received numerous prestigious awards including: 2014 Diversity Award from the American Society for Gastrointestinal Endoscopy President's Young Investigator Award from Texas Tech University (2012) Multiple ACG Presidential Poster Recipients awards (2012) Alpha Omega Alpha National Medical Honor Society Membership (2008) Multiple GRG/AGA DDW Fellow Travel Awards (2007, 2009) Multiple House Officer and Resident Research Awards from the University of New Mexico (2006-2007) Dr. Othman has secured significant research funding, including a grant from the American College of Gastroenterology for a prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct. His clinical expertise encompasses tissue resection techniques, management of pancreatic disorders, and advanced endoscopic procedures. Fluent in Arabic and Spanish, Dr. Othman serves a diverse patient population while maintaining an active research program that continues to advance the field of therapeutic endoscopy.

Matthew T. MoyerView profile

Professor

• Interventional Endoscopy
• Gastrointestinal Cancer
• Precancerous States
• +6 more

Dr. Matthew T. Moyer is a Professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Penn State Health Milton S. Hershey Medical Center. He specializes in interventional endoscopy with expertise in gastrointestinal cancer, precancerous states, pancreatic and biliary disease, inflammatory bowel disease, and gastrointestinal bleeding. Dr. Moyer's educational background includes: Medical School, Penn State College of Medicine (2002) Fellowship in Gastroenterology, Milton S. Hershey Medical Center (2008) Residency in Internal Medicine, Milton S. Hershey Medical Center (2005) His research primarily focuses on interventional endoscopy and cancerous/pre-cancerous conditions in gastroenterology. Dr. Moyer's work encompasses EUS-guided ablation of premalignant pancreatic cysts, Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), and Natural Orifice Transluminal Endoscopic Surgery (NOTES). He also develops innovative endoscopic techniques for patients with inflammatory bowel disease, leading intellectual property projects including the Chimera Project with Penn State University Bioengineering and the Quic-fuse Project with IDE Inc. of Sydney Australia. His recent publications demonstrate a strong focus on improving endoscopic techniques for polyp resection, management of inflammatory bowel disease-associated dysplastic lesions, and bleeding control. His work bridges clinical practice with technological innovation, particularly in the areas of pancreatic cyst ablation and defect closure systems. Dr. Moyer has received numerous scientific awards including: American College of Gastroenterology Governors Award for Excellence in Clinical Research (2017) Clinical Science Master Career Mentor Award, Penn State Health and Penn State College of Medicine (2023) First Place Award Winner, ACG Video Forum (2014) Inductee, Alpha Omega Alpha Medical Honor Society (2008) Investigator to Watch Award from the Center for Medical Innovation (2018) Penn State Health CAHPS Inpatient Dean's List for Extraordinary Patient Satisfaction (2017, 2018) Dr. Moyer serves as Principal Investigator for the CHARM 2 clinical trial funded by the National Cancer Institute, investigating chemotherapy for ablation and resolution of mucinous pancreatic cysts. His research has been supported by significant grant funding, demonstrating his leadership in advancing endoscopic treatments for gastrointestinal conditions. He has supervised numerous fellows and residents throughout his career, contributing to gastroenterology education. Dr. Moyer leads several innovative projects including the Chimera Project, a collaboration with Penn State University Bioengineering to develop an EUS-guided device using radiofrequency ablation and targeted external beam radiation, and the Quic-fuse Project with IDE Inc. of Sydney Australia to develop a chemoinfusion gun for EUS-guided chemoablation of pancreatic cysts.

• Gastroenterology
• Endoscopy
• Pancreatic Diseases
• +4 more

Harry Aslanian, MD, is a Professor of Medicine (Digestive Diseases) at Yale School of Medicine. He serves as Director of Endoscopic Ultrasound, Associate Director of Endoscopy, and Director of the Yale Advanced Endoscopy Fellowship. His clinical expertise focuses on advanced endoscopic procedures for pancreatic and biliary disorders, including ERCP, EUS, and endoscopic mucosal resection (EMR). He holds leadership roles in professional societies such as the American Gastroenterology Association and American Society of Gastrointestinal Endoscopy. Education: BA, Brown University, 1992 MD, Brown University, 1996 Residency, Mayo Clinic, 1999 Fellowships: Yale University School of Medicine (2002 and 2003) Research Interests: Dr. Aslanian’s work centers on advanced endoscopic techniques, pancreatic and biliary disorders, and cancer staging via endoscopic ultrasound. His research includes studies on post-ERCP pancreatitis biomarkers, polyp segmentation using AI, and clinical trials for colon polyp resection. He has authored over 100 peer-reviewed publications and guidelines. Articles Trends: His recent work emphasizes innovative endoscopic approaches, AI integration in colonoscopy, and biomarkers for procedural complications. Key themes include ERCP safety, EUS-guided interventions, and therapeutic advancements in gastrointestinal oncology. Awards: Outstanding Reviewer (VideoGIE, 2023) Fellow, American College of Gastroenterology (2018) Fellow, American Gastroenterology Association (2011) Advising & Grants: As fellowship director, he mentors trainees in advanced endoscopy. He collaborates on studies funded by NIH and industry partnerships, including trials on EUS-guided gastroenterostomy and AI-driven polyp detection. Labs/Teams: He leads the Advanced Endoscopy Program and contributes to the Pancreatic Diseases Program and Cancer Prevention and Control Center at Yale Cancer Center.

Matthew MoyerView profile

Professor

• Interventional Endoscopy
• Gastroenterology
• Pancreatic Cancer
• +2 more

Professor Matthew Moyer is affiliated with Penn State University, specializing in the Department of Medicine Division of Gastroenterology and Hepatology. His primary research areas include interventional endoscopy, cancerous/pre-cancerous gastrointestinal conditions, and endoscopic technology innovation. Gastroenterology Medical Device Development Pancreatic Cancer Inflammatory Bowel Disease (IBD) Endoscopic Surgery Dr. Moyer leads the NIH-funded CHARM II trial for EUS-guided ablation of pancreatic cysts and co-develops the Chimera Project (radiofrequency ablation + radiation) with Penn State Bioengineering. His work spans Endoscopic Mucosal Resection (EMR) , Endoscopic Submucosal Dissection (ESD) , and NOTES techniques. Recent publications highlight Randomized Trials (e.g., cold snare EMR) and Multicenter Studies (e.g., helix tacking systems). Key themes: gastrointestinal cancer prevention, bleeding hemostasis, and IBD lesion management. Scientific recognition includes: Fellow, American Society for Gastrointestinal Endoscopy (FASGE) Collaborations span institutions in the U.S. and Sydney Australia (IDE Inc.), with contributions to UN Sustainable Development Goals (SDGs) in healthcare innovation and cancer therapy.

• Interventional Endoscopy
• Gastroenterology
• Hepatology
• +2 more

Dr. Charles E. Dye is a Professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Penn State Health College of Medicine. He specializes in interventional endoscopy and endoscopic ultrasound (EUS) for managing cancerous/pre-cancerous conditions. His clinical practice includes advanced procedures like ERCP, EMR, EUS-guided ablation, and endoscopic vacuum therapy.

• Interventional Endoscopy
• Gastroenterology
• Pancreatic Diseases
• +4 more

Charles Dye, MD is a Professor in the Department of Medicine, Division of Gastroenterology and Hepatology, specializing in interventional endoscopy for gastrointestinal diseases with emphasis on pancreatic and esophageal pathologies. His research focuses on: EUS-guided ablation of premalignant pancreatic cysts (NIH-funded CHARM II trial co-investigator) Endoscopic Mucosal Resection (EMR) and cryotherapy Innovative endoscopic technologies including the Chimera Project with Penn State Bioengineering Advanced therapies for Barrett's esophagus and esophageal disruptions Recent publications (2017-2024) demonstrate leadership in randomized trials for colorectal polyp resection, pancreatic cyst ablation, and novel endoscopic techniques, establishing minimally invasive approaches as standards in gastrointestinal oncology. Dr. Dye actively collaborates on medical device development through the Chimera Project, creating EUS-guided systems combining radiofrequency ablation and targeted radiation for abdominal tumors, while contributing to UN Sustainable Development Goals through cancer prevention research.

Victoria Motz-PatelView profile

Assistant Professor

• Gastroenterology
• Hepatology
• Medical Education
• +3 more

Victoria Motz-Patel, DO serves as an Assistant Professor in the Department of Medicine with research focused on hepatology, gastroenterology, and innovative clinical interventions. Her work bridges clinical practice with academic research in liver diseases and endoscopic procedures. Her research interests prominently feature Metabolic dysfunction-associated steatotic liver disease (MASH) , nonalcoholic steatohepatitis management , hepatocellular carcinoma screening , and telehealth applications for chronic liver conditions. She investigates endoscopic techniques including hybrid argon plasma coagulation and develops multidisciplinary care models for complex liver pathologies. Her work extends to rural healthcare access challenges and emergency management of cirrhosis complications. Analysis of her publication trends reveals consistent focus on liver disease intervention across multiple dimensions: technological (contrast-enhanced ultrasound), procedural (endoscopic mucosal resection), systemic (multidisciplinary clinics), and digital (telehealth exercise programs). Her research demonstrates strong clinical translation with emphasis on practical implementation in diverse healthcare settings including semi-rural academic centers. Her scholarly contributions show significant impact with multiple publications receiving substantial citations and media attention, including coverage by news outlets and social media platforms like X (Twitter) with hundreds of reader engagements across platforms like Mendeley. Dr. Motz-Patel actively participates in collaborative research networks, particularly in gastrointestinal bleeding disorders, endoscopic techniques, and metabolic liver disease management, as evidenced by her co-authorship on multidisciplinary studies involving clinical teams across multiple specialties.

• Gastroenterology
• Endoscopy
• Endoscopic Mucosal Resection
• +2 more

Professor Michael Bourke is a Clinical Professor at the Westmead Clinical School, University of Sydney, specializing in Gastroenterology and Hepatology. His research focuses on advanced endoscopic techniques including endoscopic mucosal resection (EMR), third space endoscopy, and the management of complex colorectal polyps and Barrett's esophagus. He leads significant clinical research in therapeutic endoscopy and has contributed to developing international guidelines for endoscopic procedures. His research interests center on optimizing endoscopic resection techniques, reducing recurrence rates for large polyps, and developing innovative approaches for esophageal motility disorders. He has pioneered techniques like cold snare EMR and hybrid papillary resection to improve patient outcomes. Professor Bourke mentors research students including Sunil Gupta, exploring innovations in endoscopic tissue resection. His work involves extensive international collaborations, particularly with the European Society of Gastrointestinal Endoscopy where he contributes to position statements and technical reviews on endoscopic practices.

• Endoscopic Submucosal Dissection (ESD)
• Endoscopic Mucosal Resection (EMR)
• Peroral Endoscopic Myotomy (POEM)
• +8 more

Prof. Dr. Fatih Aslan is a renowned gastroenterologist and endoscopist affiliated with Koç University Hospital. He completed his medical degree at Uludağ University (2001), residency in Internal Medicine at Ondokuz Mayıs University (2002-2007), and gastroenterology fellowship at İzmir Atatürk Training and Research Hospital (2007-2011). Since 2021, he has been a Professor and Director of Advanced Endoscopy at Koç University Hospital, following his promotion from Associate Professor (2017-2021). His clinical focus spans advanced endoscopic techniques, including Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Sleeve Gastroplasty (ESG), and obesity management. He has performed over 10,000 advanced endoscopic procedures and pioneered several techniques in Türkiye. Prof. Aslan is an active member of leading international societies such as the American Society for Gastrointestinal Endoscopy (ASGE), European Society of Gastrointestinal Endoscopy (ESGE), World Endoscopy Organization (WEO), and the Japan Gastroenterological Endoscopy Society (JGES). He also serves on the board of the Turkish Society of Gastrointestinal Endoscopy. Scientific Awards & Recognition: World Champion of Endoscopy (2016, USA; 2022, Japan; 2025, USA) World Cup of Endoscopy Award by ASGE (2016) Best of the Best Award by ASGE (2022, 2025) He has delivered invited lectures, live demonstrations, and educational sessions at major international conferences (DDW, UEGW, JDDW, KDDW, UGH) and contributed to academic literature on endoscopic innovations.

• Endoscopic Procedures
• Gastroenterology
• Biliary Disorders
• +4 more

Ara Sahakian, MD, is a Clinical Associate Professor of Medicine at the University of Southern California (USC) and a practicing gastroenterologist affiliated with Keck Medicine of USC. He specializes in advanced endoscopic techniques, particularly in managing complex biliary and pancreatic disorders. Dr. Sahakian completed his gastroenterology fellowship at Yale University, where he earned the Samuel Kushlan Award (2012) as the most outstanding clinical fellow. His expertise includes ERCP, EUS, and endoscopic mucosal resection (EMR), with additional training in Japan for endoscopic submucosal dissection (ESD). He holds academic appointments at the Keck School of Medicine of USC and is actively involved in research on endoscopic procedure quality, colon polyp resection, and EUS-guided fine needle aspiration efficiency. Education: Yale University (Gastroenterology Fellowship, 2012) and an Advanced Endoscopy Fellowship at Yale. He also trained at Japan’s National Cancer Center for specialized EMR/ESD techniques. Research interests focus on advancing endoscopic procedures and improving clinical outcomes. His work has been published in high-impact journals like Endoscopy, Clin Gastroenterol Hepatol, and Gastrointest Endosc. Notable contributions include studies on AI-driven postcolonoscopy rescreening, antibiotic-resistant ERCP infections, and EUS-guided fiducial markers for pancreatic surgery. Dr. Sahakian’s clinical practice emphasizes minimally invasive endoscopic interventions for gastrointestinal tumors and pancreatic/biliary disorders. He is multilingual, speaking English and Spanish, and sees patients at locations in Los Angeles and Arcadia, CA.